Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...
Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...
For years, prostate cancer specialists hit a wall when prostate-specific antigen (PSA) levels crept up after definitive treatment. The cancer was likely back — but where? And to what extent? Bone plus ...
What if I Got a Whole-Body MRI? Fred Hutch and UW Medicine radiologists do not provide reinterpretations of whole-body MRIs. If you’ve had a whole-body MRI screening and have a question or concern ...
Gozellix, a PSMA-PET imaging agent, is FDA-approved for detecting prostate cancer metastasis and recurrence, enhancing access to advanced imaging. The approval is supported by data from the PSMA-PreRP ...
Whole-body screening MRI (wb-MRI) for asymptomatic patients has become a relevant topic for U.S. cancer centers. There is a growing number of for-profit centers offering wb-MRI scans for asymptomatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback